Tropical eosinophilia. A human model of parasitic immunopathology, with observations on serum IgE levels before and after treatment.
The diverse clinical syndromes characterized by asthmatic symptoms, transient pulmonary infiltrates, and eosinophilia have tended to obscure the specific association of one such entity with filarial infections. Serum IgE levels were determined before and after therapy in a group of well-characterized patients with tropical eosinophilia (TE), studied earlier in Singapore. The mean serum IgE level in 14 cases before treatment with diethylcarbamazine was 2,355 ng. per milliliter, with a trend but statistically nonsignificant decrease in levels to 600-1,000 ng. occurring 8 to 12 weeks after therapy. Leukocyte and eosinophil counts showed a rapid reduction after treatment, and although mean complement-fixing (cf) titers to Dirofilarial antigen tended to decrease, they were not significantly reduced until 5 to 6 weeks. The historical development of evidence supporting the filarial etiology of TE was reviewed. Many basic questions engendered by the clinical syndrome of tropical eosinophilia make it an excellent model for study of the immunopathology of parasitic infections.
D000906:Antibodies / Q000032:analysis; D003168:Complement Fixation Tests; D004049:Diethylcarbamazine / Q000627:therapeutic use; D004183:Dirofilaria immitis / Q000302:isolation & purification*; D004802:Eosinophilia / Q000188:drug therapy / Q000469:parasitology*; D005368:Filariasis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D005370:Filarioidea / Q000302:isolation & purification*; D006386:Hemagglutination Tests; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D011863:Radioimmunoassay; D012846:Singapore; D014330:Tropical Medicine
D000906:Antibodies; D007073:Immunoglobulin E; D004049:Diethylcarbamazine